A prospective observation study concerning the incidence of atherothrombotic events in patients with acute coronary syndrome.
Not Applicable
- Conditions
- Acute coronary syndrome
- Registration Number
- JPRN-UMIN000001128
- Lead Sponsor
- Sanofi K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients meeting any of the following criteria will be excluded from the study. 1) Chest pain and coronary diseases developed in association with other serious diseases or their treatments (e.g.: myocardial infarctions associated with car accidents, traumas, serious gastrointestinal hemorrhage or associated with vascular intervention or coronary bypass surgery) 2) Inpatients not intended for close examination/treatment of chest pain 3) Patients who are sub acute stent-thrombosis 4) Patients aged less than 20 years 5) Patients not providing a written consent by themselves or their family members 6) Patients who are disqualified the study by the investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of major adverse cardiovascular /cerebrovascular events (MACCE), including vascular death, MI, stroke since baseline to 2 years.
- Secondary Outcome Measures
Name Time Method The incidence of the primary endpoint and each following event are evaluated and the differences of each high-risk patient sub-group are examined. A) Death due to MI B) Death due to stroke C) Other cardiovascular death D) Non-cardiovascular death E) Non-fatal MI, unstable angina F) Non-fatal stroke G) Acute arterial occlusion H) Central retinal artery occlusion I) Coronary revascularization due to myocardial ischemia J) Hospitalization due to HF K) Hospitalization due to TIA L) Hospitalization due to revascularization M) Hemorrhages requiring hospitalization or blood transfusion N) Other adverse events requiring hospitalization O) Target Vessel Failure